ADPRS
Basic information
Region (hg38): 1:36088892-36093932
Previous symbols: [ "ADPRHL2" ]
Links
Phenotypes
GenCC
Source:
- neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 30100084; 30401461 |
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures (3 variants)
- not provided (3 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADPRS gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 31 | 38 | ||||
nonsense | 3 | |||||
start loss | 0 | |||||
frameshift | 4 | |||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 4 | 8 | 32 | 7 | 1 |
Highest pathogenic variant AF is 0.000105
Variants in ADPRS
This is a list of pathogenic ClinVar variants found in the ADPRS region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-36088910-C-CGCAGCGGCGATGGCG | Inborn genetic diseases | Uncertain significance (Jun 25, 2021) | ||
1-36088926-G-A | Inborn genetic diseases | Likely benign (Mar 11, 2024) | ||
1-36088927-C-T | Inborn genetic diseases | Likely benign (Oct 30, 2023) | ||
1-36088930-C-T | Inborn genetic diseases | Uncertain significance (Jul 19, 2023) | ||
1-36088936-G-A | Inborn genetic diseases | Uncertain significance (Mar 02, 2023) | ||
1-36088940-A-G | Likely benign (Jul 01, 2022) | |||
1-36088951-C-G | Inborn genetic diseases | Uncertain significance (Oct 03, 2022) | ||
1-36088957-G-T | Inborn genetic diseases | Uncertain significance (Apr 12, 2024) | ||
1-36089004-G-A | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Pathogenic (Nov 08, 2018) | ||
1-36089005-A-G | Inborn genetic diseases | Uncertain significance (Jul 28, 2021) | ||
1-36089029-C-T | Inborn genetic diseases | Uncertain significance (Jan 29, 2024) | ||
1-36089040-G-C | Inborn genetic diseases | Uncertain significance (Apr 30, 2021) | ||
1-36089040-G-T | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Uncertain significance (Jan 23, 2020) | ||
1-36089049-AC-A | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Pathogenic (-) | ||
1-36089070-C-T | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Likely pathogenic (Oct 06, 2023) | ||
1-36089070-CAG-C | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Likely pathogenic (Jun 20, 2019) | ||
1-36091266-C-T | ADPRS-related disorder | Benign (Mar 20, 2019) | ||
1-36091267-A-C | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Pathogenic/Likely pathogenic (Sep 30, 2020) | ||
1-36091270-G-T | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Uncertain significance (Mar 29, 2024) | ||
1-36091274-T-A | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Uncertain significance (Mar 29, 2024) | ||
1-36091307-A-G | Inborn genetic diseases | Uncertain significance (Jun 06, 2023) | ||
1-36091320-C-T | Likely benign (Jun 01, 2022) | |||
1-36091322-AG-A | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Pathogenic (Jan 09, 2019) | ||
1-36091333-G-A | Inborn genetic diseases | Uncertain significance (Dec 11, 2023) | ||
1-36091625-C-T | Neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures | Likely pathogenic (May 28, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADPRS | protein_coding | protein_coding | ENST00000373178 | 6 | 5058 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000575 | 0.906 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.348 | 186 | 200 | 0.931 | 0.0000110 | 2325 |
Missense in Polyphen | 54 | 74.92 | 0.72076 | 842 | ||
Synonymous | -1.07 | 97 | 84.5 | 1.15 | 0.00000492 | 756 |
Loss of Function | 1.49 | 7 | 12.7 | 0.550 | 5.41e-7 | 164 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000120 |
Ashkenazi Jewish | 0.0000994 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000988 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000497 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: Poly(ADP-ribose) synthesized after DNA damage is only present transiently and is rapidly degraded by poly(ADP-ribose) glycohydrolase. Poly(ADP-ribose) metabolism may be required for maintenance of the normal function of neuronal cells. Generates ADP-ribose from poly-(ADP-ribose), but does not hydrolyze ADP- ribose-arginine, -cysteine, -diphthamide, or -asparagine bonds. Due to catalytic inactivity of PARG mitochondrial isoforms, ARH3 is the only PAR hydrolyzing enzyme in mitochondria. {ECO:0000269|PubMed:16278211}.;
Recessive Scores
- pRec
- 0.113
Intolerance Scores
- loftool
- 0.547
- rvis_EVS
- -0.58
- rvis_percentile_EVS
- 18.59
Haploinsufficiency Scores
- pHI
- 0.252
- hipred
- N
- hipred_score
- 0.248
- ghis
- 0.602
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.968
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adprhl2
- Phenotype
Gene ontology
- Biological process
- cellular response to superoxide
- Cellular component
- nucleus;nucleoplasm;mitochondrion;mitochondrial matrix;nuclear body
- Molecular function
- poly(ADP-ribose) glycohydrolase activity;metal ion binding